Company Info
Phone(858) 997-2703
Year Established
2020
Contacts
Kleanthis G. Xanthopoulos, Ph.D.,Chair & CEO
Scott Forrest, Ph.D.
CBO
Vanessa Jacoby, CPA
CFO
Company Description
Shoreline Biosciences is a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs) utilizing its proprietary iPSC-derived natural killer (iNK) cell and macrophage (iMACs) platforms.